29 May 2024 - The European Commission has adopted joint clinical assessment rules detailing how national health care systems should review products in parallel to ensure they get to market faster in individual member states.

The Commission announced on 23 May that it had finalised the rules that it says will help member states conduct joint clinical assessments of medical products after receiving EU marketing authorisation. The rule was adopted under the Regulation on Health Technology Assessment and addressed how the evidence submitted for marketing can be used by national health authorities to assess the product by national health authorities.

Read RAPS article